sonidegib

FDA Drug Profile — Odomzo

Drug Details

Generic Name
sonidegib
Brand Names
Odomzo
Application Number
NDA205266
Sponsor
Sun Pharmaceutical Industries, Inc.
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
SONIDEGIB PHOSPHATE

Indications and Usage

1 INDICATIONS AND USAGE ODOMZO (sonidegib) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. ODOMZO is a hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. ( 1 )